Mutations in FGFR3 were associated with decreased estimates of multiple immune infiltrate types in bladder cancer and increased NK cell estimates in head and neck cancer (Table 7 and Fig 5D). This evidence concerns the gene FGFR3 and urinary bladder cancer.